Gelonghui February 1st 丨Jiuzhou Pharmaceutical (603456.SH) announced that in January 2023, the company did not implement a repurchase. As of January 31, 2023, the company has repurchased a total of 1,2573 million shares through centralized bidding transactions. The repurchased shares accounted for 0.14% of the company's total share capital. The highest transaction price was 40.96 yuan/share, the lowest price was 35.06 yuan/share, and the total amount paid was 47.2965 million yuan (excluding transaction fees).
九洲药业(603456.SH)：1月未实施回购
Jiuzhou Pharmaceutical (603456.SH): No repurchase was implemented in January
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.